In this episode, we’re talking about publications impact with Mike Taylor, Head of Data Insights and Grainne Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science.
The COVID-19 pandemic led to the biggest change in scientific congresses in a generation, with virtual meetings becoming the mainstay. In that time, we have seen many big congresses offer different options, such as virtual exhibition booths, blogs, and podcasts. As we start to go back to live or hybrid options, we will discuss what we have learnt from the last 2 years to take forward to future congress offerings. We will also explore what HCPs want when joining congresses both virtually or face-to-face.
As speed of data sharing has become front of mind, congresses have also adapted to give alternative options to share certain types of key data, avoiding the need to wait months until the next annual congress. However, questions remain regarding reach and engagement with these new options.
Finally, what do we think the congress of the future will look like. How will congresses tackle DE&I and sustainability? Will we be using avatars and joining in the metaverse or will there always be a demand for face-to-face conversations. We will share our thoughts on innovative options we think will be adopted.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
This webinar will discuss how MA colleagues are best positioned to explore the fusion of PE and PED in the post-launch phase, including generation and use of RWD and RW evidence, and will share guidance and information on several industry-supported resources, to enable MA colleagues to implement PE and evidence strategies in their function. Importantly, patient and patient advocate perspectives will also be considered, sharing opportunities, and best practice examples of how MA colleagues can overcome perceived barriers, to achieve true and impactful PE.
Following the presentation, participants will have a greater understanding of:
- Current best practice in patient engagement, from both an industry, patient advocate and patient perspective
-Â The convergence of patient experience data, real world evidence and patient engagement activity and why this is important to Medical Affairs
- What patients and their advocates need from their industry partners for better patient engagement and how this is likely to evolve
- The specific impact patient engagement can have on a Medical Affairs strategy and the various research, tools and guidance available to support this
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
In this webinar, experts will:
In this e-book, learn how medical affairs teams can use technology to address diversity issues in the drug development life cycle.
In episode 1 of this 4-part series, a panel of experts focus on the struggles and successes of compliance in Medical Communications.
This Altmetric White Paper explores how to measure the value of Medical Affairs publications beyond counting citations.
• Discuss the potential value of a co-ordinated and transparent approach to engagement planning
• Share approaches to overcoming perceived obstacles
• Explore how to get started